Clik here to view.
Revised Ph. Eur. Chapter on Raman Spectroscopy introducing PAT
The revised General Ph. Eur. Chapter on Raman Spectroscopy (2.2.48) comes into operation on April 1, 2016. The Chapter now includes hand-held devices and adaption to PAT purposes. Find out more about...
View ArticleClik here to view.
ILAPRAZOLE, IY-81149
Ilaprazole cas 172152-36-2; Iy 81149; IY-81149; 2-{[(4-methoxy-3-methylpyridin-2-yl)methyl]sulfinyl}-6-(1h-pyrrol-1-yl)-1h-benzimidazole; Aldenon; MW 366.437, MF C19 H18 N4 O2 S...
View ArticleClik here to view.
VASICINE, (peganine)
. Vasicine (peganine) is a quinazoline alkaloid. It is the active compound of Justicia adhatoda, after which the chemical is named. Vasicine has been compared to theophylline both in vitro and in...
View ArticleClik here to view.
NIZATIDINE
Nizatidine is a histamine H2 receptor antagonist that inhibits stomach acid production, and is commonly used in the treatment of peptic ulcer disease and gastroesophageal reflux...
View ArticleClik here to view.
MIANSERIN
MIANSERIN Mianserin (brand names: Depnon (IN), Lantanon (ZA), Lerivon (AR, BE, CZ, PL, RU, SK), Lumin (AU), Norval (UK), Tolvon (AU, HK†, IE†,NZ, SG†), Tolmin (DK); where † indicates discontinued...
View ArticleClik here to view.
MELOXICAM
Meloxicam ; 351.40, C14H13N3O4S2, MP 255 °C (8E)-8-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-9-methyl-10,10-dioxo-10$l^{6}-thia-9-azabicyclo[4.4.0]deca-1,3,5-trien-7-one;...
View ArticleClik here to view.
Benfotiamine
Benfotiamine S-[(Z)-2-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-5-phosphonooxypent-2-en-3-yl] benzenecarbothioate Benphothiamine; Betivina; Biotamin; Neurostop; Nitanevril;22457-89-2...
View ArticleClik here to view.
Zydus Cadila, New Patent,US 20160039759, PERAMPANEL
PERAMPANEL Zydus Cadila, New Patent,US 20160039759, PERAMPANEL (US20160039759) PROCESS FOR THE PREPARATION OF PERAMPANEL CADILA HEALTHCARE LIMITED Sanjay Jagdish DESAI Jayprakash Ajitsingh Parihar...
View ArticleClik here to view.
Cipla, New Patent, WO 2016020664, Everolimus
Cipla, New Patent, WO 2016020664, Everolimus CIPLA LIMITED [IN/IN]; Peninsula Business Park Ganpatrao Kadam Marg Lower Parel Mumbai 400 013 (IN). KING, Lawrence [GB/GB]; (GB) (MW only) RAO, Dharmaraj...
View ArticleClik here to view.
Pfizer’s Fosdagrocorat, PF-04171327 for Rheumatoid Arthritis
Fosdagrocorat, PF-04171327, CAS 1044535-58-1 (2R,4aS,10aR)-4a-Benzyl-7-((2-methylpyridin-3-yl)carbamoyl)-2-(trifluoromethyl)-1,2,3,4,4a,9,10,10a-octahydrophenanthren-2-yl dihydrogen phosphate...
View ArticleClik here to view.
WO 2016020324, BASF AG, Vismodegib , New patent
WO 2016020324, BASF AG, vismodegib , new patent WO2016020324, MULTI-COMPONENT CRYSTALS OF VISMODEGIB AND SELECTED CO-CRYSTAL FORMERS OR SOLVENTS BASF SE [DE/DE]; 67056 Ludwigshafen (DE)...
View ArticleClik here to view.
Drug Discovery, Hit to Lead
//////Filed under: Drug discovery Tagged: drug discovery, Hit to Lead
View ArticleClik here to view.
Vismodegib
Vismodegib 2-Chloro-N-(4-chloro-3-pyridin-2-ylphenyl)-4-methylsulfonylbenzamide Vismodegib; 879085-55-9; GDC-0449; 2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide;...
View ArticleClik here to view.
Biocon’s Rosuvastatin Calcium tablets get EU approval to treat hyperlipidemia
Biocon’s Rosuvastatin Calcium tablets get EU approval to treat hyperlipidemia Indian biopharmaceutical company Biocon has received approval from the European Commission for its Rosuvastatin Calcium...
View ArticleClik here to view.
Clik here to view.
Selurampanel, BGG 492
Selurampanel, BGG492, cas 912574-69-7 Chemical Formula: C16H19N5O4S Exact Mass: 377.1158 UNII-7WG1MR7DAR;...
View ArticleClik here to view.
Should Equipment Status Identification Labels be retained with the Batch Record?
Should Equipment Status Identification Labels be retained with the Batch Record? Keeping equipment status identification labels with the batch record provides additional confirmation during the review...
View ArticleClik here to view.
Zydus Cadila’s, Lipaglyn (Saroglitazar) won a lot of support at the 75th...
Lipaglyn (Saroglitazar) won a lot of support at the 75th Anniversary Conference of the American Diabetes Association. Lipaglyn is currently under Phase III clinical development for treatment of Non...
View ArticleClik here to view.
Saroglitazar, Lipaglyn by Zydus Cadila
(2S)-2-Ethoxy-3-[4-(2-{2-methyl-5-[4-(methylsulfanyl)phenyl]-1H-pyrrol-1-yl}ethoxy)phenyl]propanoic acid (αS)-α-Ethoxy-4-[2-[2-methyl-5-[4-(methylthio)phenyl]-1H-pyrrol-1-yl]ethoxy]benzenepropanoic...
View ArticleClik here to view.